SAFETY OF USTEKINUMAB IN OLDER IBD PATIENTS (>=60 YEARS): POOLED SAFETY ANALYSIS THROUGH 5 YEARS IN CD AND 2 YEARS IN UC AND ALL APPROVED INDICATIONS

Subrata Ghosh  1     Elyssa Ott  2     Christopher Gasink  2     Ye Miao  3     John Lynch  3     Aline Charabaty  4     Colleen W. Marano  4     Maria T. Abreu  5    
1 University of Birmingham, Birmingham, United Kingdom
2 Janssen Scientific Affairs, LLC, Horsham, United States
3 Janssen Research & Development, LLC, Spring House, United States
4 Johns Hopkins School of Medicine, Washington, D.C., United States
5 University of Miami Miller School of Medicine, Miami, United States

Topic
IBD

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing